Cell press lablinks are free, inperson, oneday symposia organized by scientists and cell press editors. The paradigm that drug resistance originates in the stemcell phenotype might stimulate new strategies for the development of anticancer therapies. Drug transporters in stem cells stem cells have many properties that separate them from mature, differentiated cells. Hypoxia and the accumulation of hypoxiainducible factors hifs in tumors have been associated with therapeutic resistance and with autophagy establishment.
To clarify the clinical importance of this crosstalk as a mechanism of drug resistance, we assessed the expression both of pkm2 and of cd44 in cancer cells of. The treatment of cancers, by definition, kills only drug sensitive cancer cells, and thus the drug resistance cancer cells survive and can expand and contribute to pathology over time. This paper outlines the current knowledge of mechanisms that promote or enable drug resistance, such as drug inactivation, drug target alteration, drug efflux, dna damage repair, cell death inhibition. One of the main causes of failure in the treatment of cancer is the development of drug resistance by the cancer cells.
Because the warburg effect and hypoxia are frequently seen in human cancers. The evolution and ecology of resistance in cancer therapy. Thus, a thorough understanding of apoptotic signaling pathways and insights into apoptosis resistance mechanisms are imperative to unravel novel drug targets for the design of more effective and target selective therapeutic strategies. However, if one takes the larger definition multidrug resistance as simultaneous resistance to multiple structurally unrelated anticancer therapies its existence c not be denied. Resistance to asparaginase, an antileukemic enzyme that depletes asparagine, is a common clinical problem. The emergence of acquired resistance results from host factors and genetic or epigenetic changes in the cancer cells. New molecules kill multidrug resistant cancer cells.
May 24, 2018 moreover, the gradual acquisition of specific genetic and epigenetic abnormalities in cancer cells could contribute greatly to acquired drug resistance. Apr 20, 2014 cancer stem cells linked to drug resistance date. Intrinsic drug resistance may exist in cancer cells prior to therapies due to the presence of genetic mutations of. Recent advances in apoptosis, mitochondria and drug.
Circumventing cancer drug resistance in the era of. Cancer stem cells linked to drug resistance sciencedaily. Resistance to anticancer drugs arises from a wide variety of factors, such as genetic mutations andor epigenetic. How cancer cells, with strong plasticity, orchestrate their adaptive response under sublethal drug exposure remains largely unknown.
Differential proteomic analysis of breast cancer cells with acquired resistance to rh1. Novel drug may be the answer in battling resistance in. Unfortunately, novel drug development by cell and molecular biologists, often neglects the pharmacology of a drug. Drug combinations to overcome treatment resistance. Addressing drug resistance in cancer with macromolecular. Membrane transport of chemotherapeutics and drug resistance. Collectively, these findings uncovered a novel function for the longevity gene sirt1 as a potential target for diagnosis andor treatment of cancer resistance to chemotherapy. Pdf resistance to cytotoxic chemotherapy is the main cause of therapeutic failure and death in women suffering on breast carcinoma.
Chemotherapy resistance can arise due to several host or tumorrelated factors. Cancer stem cells, which are inherently drug resistant, also display higher levels of drug efflux proteins20. Mar 15, 2016 cancer stem cells and drug resistance. Using matched drug sensitive and drug resistant ovarian cancer cells, we showed that resistance to either cisplatin or doxorubicin corresponded with an increase in tumor antioxidant capacity, defined through the elevation of intracellular gsh and a decrease in ros. We proposed a novel metabolic mechanism in cancer drug resistance where the increased capacity of the malateaspartate shuttle increased metabolic fitness, thereby facilitating cancer cells to. Mgmt genes have increased diseasefree and overall survival rates 61. Three published transcriptome microarray data were downloaded.
Drug resistance in cancer cells kapil mehta springer. With cancer drug resistance, we aim to establish a forum for papers dealing with all aspects of drug resistance. Jul 05, 2005 drug resistance is a frequent clinical problem for cancer patients. Since the vast majority of patients dying of cancer will have had anticancer therapy, both c. Since the 1940s, the primary management of advanced prostate cancer has revolved around the use of androgen deprivation therapy adt. Resistance can occur when cancer cellseven a small group of cells within a tumorcontain molecular alterations that make them insensitive to a particular drug before treatment even begins. Proteomic analysis of breast cancer resistance to the. For example, drugs can be prevented from entering the cells.
In some cases, cancers can evolve resistance to multiple drugs, called multiple drug resistance. As a dual drug loaded nanoformulation, hd nps effectively enhanced drug cytotoxicity to drug resistant cancer cells. The challenge of drug resistance in cancer treatment. This is a very serious problem that may lead to recurrence of disease or even death. With the advantage of nanosizing, hd nps could improve the intracellular drug retention of dox to as much as 2fold in drug resistant cancer cells mcf7r. While characterizing a drug resistant breast cancer cell line, mcf7advp3000, we found that fatty acid synthase fasn is overexpressed. This process selfadjusts over time, with the cancer cells emitting more pglycoprotein in each exposure to the chemotherapy agent. And the role of selected single nucleotide polymorphisms in cancer ph. The role of exosomes and mirnas in drugresistance of cancer. Modulation of multidrug resistance in cancer cells by.
The authors suggest that the implementation of in vitro drug susceptibility testing before chemotherapy can effectively prevent the occurrence of primary drug resistance and inappropriate drug treatment for individuals with lung cancer. Drug resistance and combating drug resistance in cancer. The impact of microenvironmental heterogeneity on the. Resistance to treatment with anticancer drugs results from a variety of factors including individual variations in patients and somatic cell genetic differences in tumors, even those from the same tissue of origin. This section is intended to introduce some of the main ways in which cancer cells can resist treatments. If all cells within a tumor are able to divide and inherit genetic changes to the next generation, there is a strong selection pressure for the cells to develop resistance those that are not fit will not survive. A new mechanism of drug resistance in breast cancer cells. Cancer stem cells cscs, also known as tumorinitiating cells tics, are suggested to be responsible for drug resistance and cancer relapse due in part to their ability to selfrenew themselves and differentiate into heterogeneous lineages of cancer cells. Cd44, which is a cancer stem cell marker that exhibits.
The mechanisms underlying drug resistance development are incompletely understood. The purpose of this book is to explore new concepts related to drug resistance in cancer, including resistance to the new molecularly targeted agents. Article phlda1 mediates drug resistance in receptor tyrosine kinasedriven cancer graphical abstract highlights d the akt pathway plays a critical role in resistance to tyrosine kinase inhibition d phlda1 is key to regulating akt activity during the development of drug resistance. Cancers free fulltext correlation of pkm2 and cd44.
They also describe a proof of principle that signaling pathways implicated in longevity may share similarities with those leading to development of drug resistance in cancer. In fact, drug resistance is observed in the clinic not only in cancer and pathogendriven diseases, but also in other cases. For example, poorer outcome of cisplatin treatment in gastric cancer patients was found to be associated with her2 overexpression. Apr 21, 2014 most drugs used to treat lung, breast and pancreatic cancers also promote drug resistance and ultimately spur tumor growth. Chemosensitivity and chemoresistance assays in cancer. Data show that in some cancer cells rh1 may act in an nqo1independent way. In the chemotherapy, by following the administration of a certain drug, a large number of patient tumor cells become resistant to the drug. A major obstacle in chemotherapy is treatment failure due to anticancer drug resistance. Both clinical and experimental aspects of drug resistance in cancer are included. In other cases of resistance, cancer cells may adapt to the drug while it is being administered, acquiring molecular changes that allow them to escape its effects. Because cancer cells within the same tumor often have a variety of molecular alterations, this socalled intrinsic resistance is common. Pdf chemical approaches to targeting drug resistance in. Definition of drug resistance nci dictionary of cancer. A recent cell paper highlights how changes at the chromatin level control drug sensitivity and provides insight into more effective strategies for treating cancer.
Control of multidrug resistance gene mdr1 and cancer. The new study, which was published in the journal molecular cancer therapeutics, could pave the way to reduce the risk of resistance in patients with breast cancer. However, most current research is focused on tumorspecific factors and specifically genes that. Drug resistance in cancer an overview sciencedirect topics. Cancer stem cells cscs in drug resistance and their. The combination of hcpt and dox exhibited a synergistic effect as the nanosized hd nps improved drug retention in drug resistant cancer cells against pgp efflux in mcf7r cells. Exposure to verapamil in a preclinical model of breast cancer dramatically altered the energy dynamics with cancer cells and reduced both proliferation and invasion. Pdf cancers have the ability to develop resistance to traditional therapies, and. Screening common signaling pathways associated with drug. We hope to bring together basic scientists, clinicians, and industry representatives to discuss new findings and future challenges in cancer research. Novel compounds line up to combat drug resistance in. In addition, another small fraction of adult cancer cells also possess drug resistance capabilities. Peters gj, backus hh, freemantle s, van triest b, codaccipisanelli g, van. Intrinsic drug resistance may exist in cancer cells prior to therapies due to the presence of genetic mutations of genes involved in cancer cell growth andor apoptosis.
Gsts assist in the development of drug resistance through direct detoxification and by inhibiting the mitogenactivated protein kinase mapk pathway 11. Cancer cell adaptation is required for cell survival during metastatic dissemination and outgrowth. Antitumor drug resistance remains a major challenge in cancer chemotherapy. Various mechanisms of resistance, such as abc transportermediated drug efflux, have been discovered using established model cancer cell lines. Drug resistance in cancer cells medical books free. Download pdf multidrug resistance, the principal mechanism by which many cancers. Multidrug resistance is a major problem in successful cancer chemotherapy. Drug resistant cells were generated by continuous incubation of parental cell lines with stepwise increases in drug concentration over a period of 3 to 6 months. Cancer cells express multiple drug resistance mdr by initially developing resistance to a single anticancer drug, and slowly to various anticancer agents that are structurally similar but possess different mechanisms of. The cells, viruses, or bacteria may be resistant to the drug at the beginning of treatment, or may become resistant after being exposed to the drug. The failure of cancer cells, viruses, or bacteria to respond to a drug used to kill or weaken them.
Clinically, drug resistance may develop either prior to drug therapy, or due to drug therapy. Researchers at the university of california, san diego school of medicine have discovered a biomarker called cd61 on the surface of drug resistant tumors that appears responsible for inducing tumor metastasis by enhancing the stem celllike properties of cancer cells. This was first characterized for the antifolate, methotrexate, transported by the carrier for reduced folates 3 and subsequently implicated in clinical. Measurement of tumor antioxidant capacity and prediction of. Using a genomewide crisprcas9 screen, we found a synthetic lethal interaction between wnt pathway activation and asparaginase in acute leukemias resistant to this enzyme. Resistance to anti cancer drugs can be acquired by several mechanisms within neoplastic cells, defined as 1 alteration of drug targets, 2 expression of drug pumps, 3 expression of detoxification mechanisms, 4 reduced susceptibility to apoptosis, 5 increased ability to repair dna damage, and 6 altered proliferation. Newly discovered molecules can kill multidrug resistant cancer cells by blocking cells defenses against cancer drugs, according to a new study published in. Since the vast majority of patients dying of cancer will have had anticancer therapy. We examined the effects of stable knockdown of hif1. Properties of the small group of cancer cells called tumorinitiating or cancer stem cells cscs involved in drug resistance, metastasis and relapse of cancers can significantly affect tumor therapy. Defective or inefficient apoptosis is an acquired hallmark of cancer cells. Categories of mechanisms that can enable or promote direct or indirect drug resistance in human cancer cells. Health, general biological sciences science and technology, general alkaloids health aspects anthracyclines apoptosis cancer care and treatment cancer cells celandine usage. Targeting cancer cell metastasis by converting cancer cells.
Oct 08, 2019 a small subpopulation of cancer cells within a tumor mass possesses characteristics associated with stem cells, thus designated cancer stem cells cscs. Thus, it is important to understand the characteristics and mechanisms by which cscs display resistance to therapeutic agents. Our study shows a promising therapeutic strategy to effectively kill cancer cells and overcome drug resistance. The role of autophagy and apoptosis in the drug resistance of cancer. During decades of research, different mechanisms for mdr was. Perhaps new terminology is needed for resistance that occurs following therapy with the targeted agents.
Progress in understanding the molecular basis of drug resistance in cancer promises more effective treatments. We found that under normoxic conditions, malignant cells exhibit increased basal levels of autophagy. Elevation of gst expression in cancer cells enhances detoxification of the anticancer drugs, which results in less efficient cytotoxic damage of the cells 12. Here we investigated the mechanism of acquired resistance to a novel anticancer agent rh1 designed to be activated in cancer cells by the nqo1 enzyme. Analysis of tumorderived cell free dna in blood yields insights into drug resistance in patients with castrationresistant prostate cancer romanel et al. Even though the process of drug design has become exceedingly sophisticated in recent years, there is not a single drug available that is 100% effective against metastatic cancer. Early in the era of modern cancer chemotherapy, transport across cell membranes by carriermediated processes was recognized as an important determinant of drug activity and resistance.
Drug resistance as a biochemical target in cancer chemotherapy covers the proceedings of the th bristolmyers squibb symposium on cancer research, entitled drug resistance as a biochemical target in cancer chemotherapy, hosted by the japanese foundation for cancer research in tokyo. Cancer stem cells cscs are a subpopulation of cancer cells with high clonogenic capacity and ability to reform parental tumors upon transplantation. Here, we aimed to identify the common signaling pathways involved in drug resistance in non. Mirnas loaded in these exosomes might be transferred to recipient niche cells to exert genomewide regulation of gene expression. Cancer is a systemic heterogeneous disease that can undergo several rounds of latency and activation. University of california, san diego health sciences summary. The different mechanisms of cancer drug resistance. Antineoplastic resistance, often used interchangeably with chemotherapy resistance, is the resistance of neoplastic cancerous cells, or the ability of cancer cells to survive and grow despite anti cancer therapies.
The fbxw2msx2sox2 axis regulates stem cell property and. A critical issue in the clinical setting, is that the problem of drug resistance appears to have a negative effect on also the new molecularlytargeted anticancer drugs. Download and read free online drug resistance in cancer cells from springer. One feature common among drug resistant and metastatic tumor cells is an increased resistance to apoptosisthe ability of cancer cells not only to grow and survive successfully in the stressful. Many drugs have been designed or discovered and used to kill cancer cells. The resistance of cancer cells to various therapeutic agents and modalities is a crucial issue in clinical oncology. Drug combinations to overcome treatment resistance national.
Malignant tumors evolve through dynamic responses to microenvironmental signals and development of resistance following therapeutic interventions. Cd44, a surface marker for cancer stem cells, interacts with pkm2, a key regulator of aerobic glycolysis, and enhances the glycolytic phenotype of cancer cells leading to antioxidant protection and macromolecules synthesis. Get the most important science stories of the day, free in your inbox. The establishment of chemoresistant cancer cell lines might be one of the useful model systems to study molecular mechanisms leading to cancer drug resistance. Cancer chemotherapy resistance mdr is the innate andor acquired ability of cancer cells to evade the effects of chemotherapeutics and is one of the most pressing major dilemmas in cancer therapy. Overcoming multidrug resistance in cancer stem cells. Modulation of multidrug resistance in cancer cells by chelidonine and chelidonium majus alkaloids. Department of medical microbiology and immunobiology faculty of medicine university of szeged szeged 2012. Resistance to therapy has been shown for several types of csc and, therefore, they have been. The stem cell model of drug resistance is an important step forward in the field of cancer drug resistance because it gives us an avenue to explain how cancers which show an apparent complete clinical response to chemotherapy can relapse either within months or even years later. Cancers have the ability to develop resistance to traditional therapies, and the increasing prevalence of these drug resistant cancers necessitates further research and treatment development. Cancer drug resistance is an open access journal, focusing on pharmacological aspects of drug resistance and its reversal, molecular mechanisms of drug resistance and drug classes, etc.
Most drugs used to treat lung, breast and pancreatic cancers. Cscs exhibit the ability of selfrenewal and multilineage differentiation, which is responsible for tumor initiation, progression, metastasis, drug resistance, and tumor recurrence. One of the main causes behind the failure of treatment is the development of various therapy resistance mechanisms by the cancer cells leading to the recurrence of the disease. Abc transporters, drug resistance, and cancer stem cells. When a drug reaches a tumor, the cancer cell has an extensive. Importantly, tumor drug resistance seems to be closely. Additionally, the polymers showed anticancer efficacy in a hepatocel.
Generation of cisplatinresistant ovarian cancer cell lines. The purpose of this study was to identify differentially expressed genes associated with acquisition of resistance in human gastric cancer cells. The design of cancer chemotherapy has become increasingly sophisticated, yet there is no cancer treatment that is 100% effective against disseminated cancer. The purpose of this book is to explore new concepts related to drug resistance in cancer, including resistance to.
How exosomal mirnas contribute to the development of drug resistance in the context of the tumor microenvironment has not been fully described. Role of abcg2 in multi drug resistance and cancer stem cell. One biochemical mechanism for resistance is when cancer cells emit a substance called pglycoprotein, which can remove the chemotherapy drug from the cancer cell. Here, we hypothesize that the local tumor microenvironment could influence the magnitude and directionality of the selective effect, both in the presence and absence of a drug. Nanodrug formed by coassembly of dual anticancer drugs to. Concurrent experiments with the smallmolecule chemotherapeutic, doxorubicin, show aggressive resistance onset in cancer cells, a lack of efficacy against drug resistant cancer cell lines, and a failure to prevent cancer cell migration.
One such example is resistance to platelet inhibitors 43, where overexpression of the drug target is one of the mechanisms that lead to failure of treatment. Drug resistance, epigenetics, and tumor cell heterogeneity. Ivermectin reverses the drug resistance in cancer cells. One way cancer cells accomplish this is by catching the intruding drug and throwing it out of the cell before it can act. Thus, when the tumor cell detects the presence of these fake drugs, it uses its resistant mechanisms such as the mdr1 system to pump the drug from the cytosol. Identification of genes with differential expression in. Cancer cells express multiple drug resistance mdr by initially developing resistance to a single anticancer drug, and slowly to various anticancer agents that are structurally similar but possess different mechanisms of action.
The ovarian cancer cell lines a2780 and igrov1 and corresponding cisplatin resistant cells were a. Apr 27, 2017 overcoming cancer treatment resistance. A recent cell paper highlights how changes at the chromatin level control drug sensitivity and provides insight into more effective strategies for treating cancer with combination therapies. The inability of cancer drugs to destroy metastatic tumors is the major reason why cancer therapy fails. Novel compounds line up to combat drug resistance in cancer cells.
592 507 1457 1422 1408 857 149 449 1388 1 673 348 169 1163 379 84 495 1322 424 729 92 476 698 833 841 279 33 1256 162 1292 1157 1007 214 1419 606 900 976 300 889 832 1063